Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rubius Therapeutics Inc.

    NASDAQ: RUBY · Real-Time Price · USD
    0.06
    0.00 (8.11%)
    At close: Dec 29, 2023, 9:49 PM

    Rubius Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -127K -61.58M -42.91M -50.86M -53.73M -50.05M -49.92M -40.92M
    Interest Income
    		 124K 392K 255K 48K 16K 23K 26K 26K
    Pretax Income
    		 -20.14M -62.87M -44.24M -52.41M -55.02M -49.02M -50.18M -42.33M
    Net Income
    		 -41.28M -92.92M -45.58M -53.96M -55.02M -49.02M -50.18M -42.33M
    Selling & General & Admin
    		 1.06M 7.3M 9.91M 12.56M 13.9M 12.04M 13.85M 13.24M
    Research & Development
    		 888K 24.23M 33M 38.3M 39.82M 38.01M 36.07M 27.68M
    Other Expenses
    		 1.7M 53K 40K 31K -1.29M 2.72M 1.03M 309K
    Operating Expenses
    		 1.95M 31.53M 42.91M 50.86M 53.73M 50.05M 49.92M 40.92M
    Interest Expense
    		 -1.13M 1.74M 1.63M 1.63M 1.66M 1.71M 1.31M 1.75M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1.95M 31.53M 42.91M 50.86M 53.73M 50.05M 49.92M 40.92M
    Income Tax Expense
    		 21.14M 30.05M 1.33M 1.55M 1.66M 4.43M 2.34M 2.06M
    Shares Outstanding (Basic)
    		 90.43M 90.36M 90.26M 90.15M 89.92M 89.81M 89.52M 82.31M
    Shares Outstanding (Diluted)
    		 90.43M 90.36M 90.26M 90.15M 89.92M 89.81M 89.52M 82.31M
    EPS (Basic)
    		 -0.46 -1.03 -0.5 -0.6 -0.61 -0.55 -0.56 -0.51
    EPS (Diluted)
    		 -0.46 -1.03 -0.5 -0.6 -0.61 -0.55 -0.56 -0.51
    EBITDA
    		 -28.62M -61.58M -41.01M -49.22M -53.73M -45.99M -47.35M -39.09M
    EBIT
    		 -20.7M -61.14M -42.61M -50.78M -51.43M -47.3M -48.87M -40.58M
    Depreciation & Amortization
    		 427K 33.17M 1.89M 1.64M 3.39M 1.32M 1.52M 1.5M

    Add to Watchlist